$2.2B Bayer New Albany Pharmaceutical Campus: Company Unveils Ohio Manufacturing Plan
Article excerpt
Highlighted: the sentence this signal was extracted from
Bayer has announced plans to invest $2.2 billion in a new pharmaceutical manufacturing campus in New Albany, Ohio. The Bayer New Albany campus will combine drug substance and drug product production across two modules, with the first scheduled to become operational in 2031. The project is expected to create around 600 permanent jobs. Announced on October 2 with Ohio Governor Mike DeWine and JobsOhio, the investment builds on more than $7 billion that Bayer has spent on US pharmaceutical research and manufacturing over the past five years. In addition, Bayer describes the campus as its first major greenfield pharmaceutical production project in North America. The company also intends the site to anchor a US collaboration ecosystem that links academic research with advanced manufacturing expertise, and Ohio State University president Ravi Bellamkonda said university researchers will work alongside Bayer teams. Meanwhile, the First Solar Innovation Center in Perrysburg shows how Ohio has already delivered a large research asset beside existing production. First Solar announced the facility in 2022 with a $270 million price tag, and it opened in July 2024 as the Jim Nolan Center for Solar Innovation. The company describes the 1.3 million square foot site as the largest solar R&D facility in the Western Hemisphere, and JobsOhio reports that it has created 180 jobs. Furthermore...
Keep reading with a free account
The rest of this article, and every signal for Bayer, is in your free account.
